Advanced Search
Contact | Corporate | Help

Daily news email for May 23, 2012 | Click here for updated news

SourceSolution News
We want to hear from you! Click here let us know how we can make this news email better.

Manage projects more efficiently. Try PlanIt free for 15 days.

Create quality questionnaires and RFPs more quickly, weight responses and manage suppliers.

Discounted advertising rates on www.sourcesolution.com for all BIOCOM members starting at $100/month

Use PlanIt as your next deal room! Click here to learn more.

 b3c newswire
Zytoprotec Completes Phase I/II Trial of Novel Dialysate, Enters Into Negotiations with Global ...

ElexoPharm Receives 2.1 Million EUROSTARS Grant for Program Targeting Mitochondrial ...

Vetter Boosts Quality and Logistic Processes

Definiens Expands Functionality of Its Leading Solution for Quantitative Digital Pathology with ...

Antisense Pharma Internationalizes Management Board

 BioSpace
Allergy Therapeutics plc: Notification of Voluntary Product Recall of Anapen by

Veloxis Pharmaceuticals A/S to Restructure and Cut Staff

Seattle Genetics, Inc. Follows the Science, Taking on Rare Lymphoma No. 3

Seahorse Bioscience Raises $9.4 Million for Biotech Labware

PPD, Inc. Names Chairman and CEO

BioSpace - Breaking News
Apofore Founder Publishes Studies Identifying Apolipoprotein A-IV as New Potential Target for Type 2 Diabetes Therapeutics

AVEO Oncology (Formerly known as AVEO Pharmaceuticals, Inc.) Initiates Phase 1 Study of AV-203, an ERBB3 Inhibitory Antibody, in Advanced Solid Tumors

Zytoprotec Completes Phase I/II Trial of Novel Dialysate, Enters into Negotiations With Global Pharmaceutical Company

Insmed Incorporated Begins Screening Patients For TARGET-NTM U.S. Clinical Trial Of ARIKACE In Patients With Non-tuberculous Mycobacterial Lung Disease

Furiex Pharmaceuticals, Inc. Confirms Takeda Pharmaceutical Co. Ltd.'s Announcement on the Acceptance of the Submission of Alogliptin for the Treatment of Type 2 Diabetes

Biotech News - Business Wire
Halo Healthcare, Inc., Makers of the HALO® Breast Test for Risk Assessment and Early Detection of Breast Cancer, Announces New Organization

Fresenius Medical Care Launches Expanded Dialysis Patient Education Initiative

Research and Markets: Livestock Epigenetics: Information on this Rapidly Expanding Field of Research from a Global Team of Experts

Makucell Selected as a Cool Company by the San Diego Venture Group

Passeo-18 Lux

 Biotech News - PR Newswire
Mylan Launches Generic Version of Viramune® Tablets

Leader in Antibacterial Phage Technology Micreos Secures Growth Capital

Everett Laboratories, Inc. Files Patent Infringement Lawsuit Against Competitor Trigen Laboratories, Inc.

Exosome Diagnostics Presents Data at American Urology Association Demonstrating Potential Utility of Urine Exosomes to Non-invasively Detect and Manage Prostate Cancer

Ariosa Diagnostics Announces Publication of Study on Influential Factors Affecting Fetal DNA Concentration in Blood of Pregnant Women
Biotechnology - Moreover
Analysis of Relative Performance in the Biotechnology Industry for Shares of Incyte (INCY, ONXX, ALKS, SPPI, MITI)

Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (CPHD, IMGN, HGSI, SGEN, RIGL)

NIH Translational Center Should Raise All Boats, BIO Says

Immunogen, inc. reports second quarter fiscal year 2012 financial results and provides quarterly update

Biotechnology to be 21st-century industry: Life Tech CEO

 Burrill Report
The June 2012 Issue of The Burrill Report

European Private Investment Fundraising Up 80 Percent

Military Veterans Support Alternative Fuels

Kythera Files to Go Public Under JOBS Act

International Doctors' Group Criticizes Gates Global Vaccines Plan

 CenterWatch - Clinical Trials
Sanofi's $20 billion Genzyme buy could fuel a big pharma-biotechnology acquisition trend

New Quintiles initiative saves investigative sites the time, and cost, of patient recruitment advertising

Technology companies adapt interactive video concepts for clinical trial informed consent

CRI buys Lifetree, combining investigative sites on both coasts and across all trial phases

New $1b NIH center will tackle early-stage drug development to ease industry risk of failure
Clinical Trials - Business Wire
Texas Researchers Studying Breast Cancer Prevention, Minorities and More Effective Treatments with $8.4 Million in New Research Funding from Susan G. Komen for the Cure®

Tryton Announces Positive Clinical Data from More Than 900 Patients Treated with Its Bifurcation Stent System at EuroPCR 2012

Research and Markets: Hyperphosphatemia Global Clinical Trials Review, H1, 2012

Air Techniques Proudly Sponsors the First Annual Northern Illinois Oral Cancer Awareness Walk

Nevro Receives FDA Approval to Initiate Landmark U.S. Randomized Pivotal Trial of Innovative Chronic Pain Treatment

 Clinical Trials - PR Newswire
Immune cells "sculpt" circuits in the brain -- by eating away excess connections

Uptake Medical Announces Positive 12-month Outcome Data for InterVapor Therapy for Severe Emphysema

Heart disease and stroke deaths drop significantly for people with diabetes

Analysis of Patient Pathways Highlights Key Role of Home Healthcare in Clinically Appropriate & Cost Effective Care

University Hospitals Case Medical Center Surgical Oncologist Presents Promising Data for Novel Pancreatic Cancer Vaccine

 CNN Top Stories
Doctor linked to bin Laden capture jailed

'Finally, Egypt is born'

Edwards jury still out

Plane diverted after implant claim

Pres. Reagan's blood for sale online
Contract Pharma
Harlan Adds to Pharma Leadership Team

PSI Names Latin American Leader

Recipharm Plans To Expand

OmniComm, Veeda in Preferred Program Pact

Pfizer Appoints BU Executives

 FDA Drugs- What's New
Comunicado de la FDA sobre la seguridad de los medicamentos: Recomendaciones modificadas para observación cardiovascular y uso del medicamento Gilenya (fingolimod) para la esclerosis múltiple

Comunicado de la FDA sobre la seguridad de los medicamentos: Recomendaciones modificadas para observación cardiovascular y uso del medicamento Gilenya (fingolimod) para la esclerosis múltiple

Comunicado de la FDA sobre la seguridad de los medicamentos: Informe actualizado sobre la seguridad del medicamento Revlimid (lenalidomida) para el cáncer y el riesgo de nuevos tipos de neoplasias (nuevos tipos de cáncer)

Comunicado de la FDA sobre la seguridad de los medicamentos: Informe actualizado sobre la seguridad del medicamento Revlimid (lenalidomida) para el cáncer y el riesgo de nuevos tipos de neoplasias (nuevos tipos de cáncer)

FDA Drug Safety Communication: Revised recommendations for cardiovascular monitoring and use of multiple sclerosis drug Gilenya (fingolimod)

 FDA News - Business Wire
MDLinx Survey: Ninety Percent of US Oncologists Report Crucial Cancer Drug Shortage

BroadcastMed Changes Bariatric Business

Texas Workers Compensation Dept. Adopts Medical Treatment Guidelines Recommending STAR Ankle Replacement System Exclusively

Furiex Confirms Takeda's Announcement on the Acceptance of the European Medicines Agency Submission of Alogliptin for the Treatment of Type 2 Diabetes

Tonix Pharmaceuticals CEO Interviewed on CEOLive.TV
FDA Press Releases
U.S. Marshals seize unapproved new drug from Crescendo Therapeutics LLC

FDA-led research team discovers an autoimmune mechanism for serious drug-induced adverse reactions

FDA approves generic versions of blood thinner Plavix

FDA expands use for FilmArray Respiratory Panel

FDA issues alert on potential dangers of unproven treatment for multiple sclerosis

 FDA Vaccines, Blood and Biologics - What's New
Moon Marine USA Corporation voluntarily recalls frozen raw yellowfin tuna product Nakaochi Scrape associated with a multistate outbreak of Salmonella Bareilly infections

Multi-Center Fellowship in Regenerative Medicine

FDA Webinar on Safety of the Blood Supply

WinRho SDF Liquid

Flebogamma DIF 5%

 FierceBiotech
Halo garners support for PhII DMD study

GSK tweaks Human Genome bid to include poison pill antidote

The biggest R&D spenders in biotech

Novo confident that it can crack blockbuster oral insulin market

French biotechs afflicted by a plunge in financial support

FierceBiotech IT
Relay launches 'Bloomberg' for biopharma dealmakers

Memorial Day break; Twitter chat reminder

Ex-Apple CEO forecasts tech-driven change in medicine

Accelrys snaps up discovery software from Scynexis

Med device companies split on social media use

 FierceBiotech Research
New strategy reactivates genes to suppress cancer

Malaria's genetic secrets open door to new drug targets

2 proteins appear crucial for aggressive cancer metamorphosis

Celery extract shrinks difficult breast cancer tumor in mouse trials

Researchers find novel way to treat anxiety

 FiercePharma
Study: Docs barring pharma reps has unexpected side effects

Pfizer taps new emerging markets chief as Simmons exits

NICE nod for Xarelto as FDA panel mulls new use

Pfizer adds healthy-eating app to Lipitor marketing arsenal

Merck CEO assures shareholders there is life after death of Singulair patent

FiercePharma Manufacturing
Counterfeit drugs threaten strides against malaria

Cipla partnership plans $50 million expansion in Uganda

FDA inspectors cite problems at Impax California plant

Chinese court favors J&J in distribution fight

Pfizer recalls 653,000 bottles of smelly Advil

 FierceVaccines
Carbohydrate, vaccine combination could push melanoma immunotherapy forward

Nasal HIV vax safe, triggers immune response

Biovest makes a move on the EU market with BiovaxID

Inovio makes steps towards a universal flu vax

Existing drugs boost new cancer vax responses

 Health News - BizJournals.com
Prime Therapeutics hires new CFO

Audit IDs ways to improve mental health delivery to kids

WEA Trust sees its activity rebounding

XDx links with LabCorp in lupus license deal

Furiex Pharma to receive $10M milestone payment

Health News - CNBC
NBC-WSJ Poll: Obama-Romney in Tight Race

Pfizer emerging markets head leaving for PPD

Mesa Laboratories 4Q profit little changed

Miracle sweetener stevia may have a sour note

Docs win most malpractice suits, but road is long

 Health News - Fox Business
Employers Grateful for Proposed Tax Breaks, But Still Scared

Employers Grateful for Proposed Tax Breaks, Still Scared

Insmed Shares Drop as FDA Halts Study After Rat Test Results

Week Ahead: A Flood Of 2Q Earnings

Pfizer Drug Raises Heart Attack Risk: Study

 Inside Industry - Gen
Nexavar Fails to Meet Primary Endpoint in Late-Stage NSCLC Study

France's Biotech Industry Faces Financing Challenge but Partnership Growth

Nexavar Fails to Meet Primary Endpoint in Phase III NSCLC Study

Shire Reports Positive Phase III Data to Support European Filing of ADHD Drug Vyvanse

Veloxis Restructures to Focus on Late-Stage Once-Daily Immunosuppressant
Marketwire - Pharma and Biotech
Insception Biosciences Inc. Proudly Announces FACT Accreditation

BIOTRONIK annonce des rltats positifs du stent Pulsar dans le cadre de l'de clinique 4EVER

RadMD Expands Its Imaging Expertise Services With New European Office

PharmaPros Launches Technology Agnostic Data Hub

IBEX fait le point dans le cadre de sa poursuite contre JF Gareau/Garvinci

 MassBio News
MassBio Honored with NORD's Power of Partnership Award

10 reasons to attend the BIO International Convention

New Therapy Helps Patients Soar to New Heights

BIO 2012 Massachusetts Pavillion Patient Profiles

By Popular Demand: New Professional Development Courses Aim to Meet Industry Needs

 Medical Pharma - PR Newswire
Janssen Healthcare Innovation Announces Discharge Decision Support System (D2S2) Winner of the Janssen Connected Care Challenge

New iPad App Accent HD Takes Medical Dictation and Transcription Mobile

Hill-Rom to Participate in the Goldman Sachs 33rd Annual Global Healthcare Conference

Most People Visit the ER Because "Only a Hospital Could Help;" CDC Report Highlights Lack of Access to Care

Chicago-area Pediatric Cancer Charity Gets a Surprise from Taylor Swift
National Center for Biotechnology Information
GTR News

GEO Series Releases

ClinVar News and Announcements

Behind The Headlines - Health News from NHS Choices

PubMed Health Featured Reviews

 Nature Biotechnology
High-efficiency TALEN-based gene editing produces disease-resistant rice

Recasting natural product research

A work in progress

Drug pipeline: 1Q12

Biotech equities heat up in 1Q12

 New York Times- Biotechnology
DEALBOOK; Human Genome Sciences Rejects A $2.59 Billion Bid From Glaxo

White House Promotes a Bioeconomy

George Rathmann, Chief of Amgen, Dies at 84

Cost of Gene Sequencing Falls, Raising Hopes for Medical Advances

Cancer Center, in Suit, Claims Ex-Official Took Research
New York Times- Pharmaceuticals
Fake and Substandard Drugs Grow as Threat to Fight Malaria

Tailoring Treatments for Alcoholics

A New Attack on Alzheimer’s

A Stem-Cell-Based Drug Gets Approval in Canada

WELL; F.D.A. Is Wary Of Lengthy Use Of Bone Drugs

 OnBioVC
S.E.A. Medical Systems, Inc.: Series B $3M

Phosphate Therapeutics, Ltd.: Series A $13.8M

CrystalGenomics, Inc.: Series A $2.6M

Heat Biologics, Inc.: Series A $2.8M

CN Creative, Ltd: Series A $3.1M

 Outsourcing-Pharma
R&D and commercial work together to design trials, says DIA

Patheon launches CMC consultancy in face of restructuring plans

SGS adds formulation development services and expands US lab

Once a friend now an enemy: Over zealous EU regulators could hamper the CMO market, says analyst

Pharmas must give patients voice says DIA Europe director
Pharma News - Business Wire
NeuroMetrix to Exhibit at AACE Annual Meeting

ISR's New Report Uncovers Barriers and Strategies in Investigator Recruitment

PHT Corporation to Convene Global Biopharmaceutical Clinical Research Leaders at 16th Annual PRO & ePRO Congress

KIYATEC Announces Initial Close on Series A Funding Round

New Health Report da Quintiles avalia a equação de risco na medicina biofarmacêutica

 Pharma News - PharmiWeb
Aetna and Silverlink Selected as Finalists in 2012 TripleTree iAwards for Innovative Program to Help Members Better Manage Diabetes

Blue Cross Blue Shield of Michigan and 12 hospitals across the state work to improve quality of hip and knee replacement surgery

Suffolk Construction To Build INOVA Fair Oaks Hospital's New Medical Office Building IV

Texas Children's Hospital, Baylor College of Medicine radiologists gain international recognition at the Society for Pediatric Radiology's 2012 annual meeting

Drivers of mHealth Models in Africa & the Middle East

 Pharma News - PR Newswire
Akrimax Pharmaceuticals announced the launch of Suprenza (phentermine HCl) orally disintegrating tablets (ODT) for the management of exogenous obesity

Endo Health Solutions Inc. Announced as New Name for Endo Pharmaceuticals Holdings Inc.

New Drug Application for Regorafenib for the Treatment of Metastatic Colorectal Cancer Submitted by Bayer

Anatabloc® Retail Expansion with GNC Complete: Product Now Available at all GNC Corporate Stores and GNC.com

QRxPharma Granted Additional US Patent on MoxDuo®
Pharmaceutical - Moreover
: Pharmaceuticals look to cure pipeline concerns

Drug firms sign up to new tropical disease fight

Cannabis Science Presents Newest Photographs From 3rd Cancer Patient That Show Cancer Tumors Dying and Areas That Are No

Micro Labs attracts private equity and pharma interest: VCCircle

Novartis net dips by 5.3% to Rs.38 crore in Q3

 PR Leap - Biotech
SHEL LAB Introduces the Bactrox Chamber

Abcam Launches Potent, Novel Dynamin Inhibitor Licensed from the University of Newcastle and Children's Medical Research Institute

Abcam Biochemicals is launched; the new name for Ascent Scientific products

AL-TAR Services, Inc. Adds Thermo-Scientific Product Line to its Online Lab Equipment Store

Ascent Scientific Launch Novel Dynamin Inhibitor Dyngo-4a™ with Children's Medical Research Institute and University of Newcastle

 PRWeb - Biotechnology
Medical Replacement Parts Distributor, Alpha Source, Inc., to Exhibit...

ECOG Foundation Awards Young Investigators for Research Initiatives

Selexis SA and Fusion Antibodies Services Form Partnership to Speed...

November Research Group Appoints Bio-Pharmaceutical...

QualityStar's Quality Consortium Receives Approval by the American...
PRWeb - Pharmaceuticals
Dermataloge, Now Offering the Latest Photodynamic Cosmetic Treatment,...

The American Society for Pain Management Nursing to Present at...

Jarrow Formulas Launches Phosphomega, an All-New Bioavailable...

Newly-Approved BELOTERO Balance® Dermal Filler Available at...

VSolvit LLC Receives Grand Challenges Explorations Grant For...

 Scientific American
U.S. Government Sets Out Alzheimer's Plan

Apocalypse Soon: Has Civilization Passed the Environmental Point of No Return

Can Soil Sensors Save Georgia Waterways from Drought

2-Hour Therapy Cures Spider Phobia by Rewiring the Brain

Flexible Plastic Electronic Display Company Exits E-Reader Market

 Sports - ESPN Basketball
Reports: Binghamton to hire Rider's Dempsey

Indiana schools will keep Crossroads Classic

UNC Wilmington's Smith transfers to Va. Tech

Big East mulls integrating new members within conference schedule

King: Groce determined to get Illinois back on the right track
Sports News - ESPN
Maisel: Leaving is the Pitts

Vols TE Clear charged with stealing thousands

Tulsa suspends starting LB Jackson 3 games

Iowa St.'s Gary gets probation in robbery case

Paterno earned $13.4M pension at Penn State

 Xconomy Life Sciences
Analytic Software Wins Janssen Prize to Reduce Hospital Readmissions

Ra Pharma Pours $8.6M Into Discovery Tech and New Rare-Disease Drug

Seattle Genetics Follows the Science, Taking on Rare Lymphoma No. 3

San Diego BizTech Roundup: Qualcomm, Helix Wind, and 'skqueak

San Diego's Free EvoNexus Tech Incubator Gains Qualcomm Expertise

 Yahoo Biotech News
Slow, costly process stymies generic biotech drugs (Reuters)

Analysis: Slow, costly process stymies generic biotech drugs (Reuters)

Waves Break Coral Embryo into Identical Twins (LiveScience.com)

Autoinjector Version of MS Drug Approved (HealthDay)

Fake Avastin had salt, starch, chemicals: Roche (Reuters)


SourceSolution © 2008-2012